An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
about
Mechanisms of drug resistance in colon cancer and its therapeutic strategiesProfiling and targeting HER2-positive breast cancer using trastuzumab emtansineZoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cellsCapsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced AutophagyTrastuzumab emtansine: mechanisms of action and drug resistanceThe down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells.Reversal of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR by LY980503.Antitumor agents. 280. Multidrug resistance-selective desmosdumotin B analoguesTRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinomaABC transporters: unvalidated therapeutic targets in cancer and the CNSNuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells.ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrierCurrent and emerging therapies for advanced adrenocortical carcinoma.Multidrug-Resistance Related Long Non-Coding RNA Expression Profile Analysis of Gastric CancerThe nuclear epidermal growth factor receptor signaling network and its role in cancer.Current and emerging therapeutic options in adrenocortical cancer treatment.A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs.Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FUAntitumor Agents 291 Expanded B-Ring Modification Study of 6,8,8-Triethyl Desmosdumotin B Analogues as Multidrug-Resistance Selective AgentsVEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in JapaneseShort hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells.Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunitiesReversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer.Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy.Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumorsQuinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans.Bullatacin triggered ABCB1-overexpressing cell apoptosis via the mitochondrial-dependent pathway.Protein kinase Cα protects against multidrug resistance in human colon cancer cells.Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.Bioengineering approaches to study multidrug resistance in tumor cells.Nanopreparations to overcome multidrug resistance in cancer.Overcoming multidrug resistance with nanomedicines.
P2860
Q26738528-178A6E1C-B081-4656-B35A-A597B052B8D5Q27015048-DEE2012A-71B4-45EA-A977-FB9D08AD76CEQ28486174-CFAFAE8B-65AF-4B3C-B150-9600C21F274FQ28546914-5FC1328A-F1FE-4986-93E5-E3F1E7A19E86Q33759627-DE931D46-7D45-4FC1-B1F1-C7F91FEEEC4FQ33812772-4173D9C4-6BEC-4D01-8987-96F862D98BC1Q34098942-3E1B0242-9311-450F-8A4E-D6030B193A5CQ34153747-2B07A536-456B-43DA-A021-762DCA7D1898Q34365715-00C83CBD-B838-42A8-8564-7D7FE97CB7E5Q34994901-8524A764-BD8A-4991-B043-FC0DA5A9F33CQ35012043-5BB140CF-C352-4693-BAE5-0D6D8FFBA2D1Q35056738-92B52609-E244-46CC-89D2-97E78E1CFF9BQ35063410-4AFC5B73-E67F-4424-97A2-3C166DF72337Q35064133-DD7FC26C-DC4F-4AC8-9944-1AECADB37BBFQ35171274-1B6D1F4E-1677-46EF-9A96-193B14DAFC09Q35546832-142E06BF-D0CE-4E25-A3A3-2803E40015EAQ35584305-0DDE3358-24F6-4D47-AFE8-D4AD0B60D57EQ35751343-5AE7E7F8-83E5-488B-A7C1-422CF9CC8BB8Q35834849-818E867B-1859-4819-9AEA-B15780083DFFQ36183873-77D38529-6B5C-4820-891E-C804954822F3Q36259762-F97EA772-A5FE-4968-BD43-A5BA3B8FB4E5Q36390281-174E6AA8-3A28-4812-89BC-10B711852A8EQ36509179-D3A75D4B-B363-4D5B-B523-F4D2588CD7CAQ36541140-3547CA5A-8D31-47A4-AC52-DE80E0DB23BEQ36642129-5E73A30F-6560-4D87-9FF1-F54EB545D2F4Q36960756-B9FEE7A6-965F-4A6A-8536-6430AB73541FQ37010772-E3FF68B3-F6EF-44F1-854F-DD37E0A7CBFEQ37065575-8CC63FF7-3D82-4B0E-9379-6E77BADB8F91Q37067185-89A316DF-3287-4577-8863-9E79C272520DQ37076348-DAB784A0-F5A7-4F55-98F3-A3FED2C633FDQ37209072-70C7DC61-B1A3-4DF4-8B96-39312AA8DA8DQ37230670-EB6A718F-C33E-470C-B4DE-4E43716B74BFQ37247862-B46AA7BE-D1BF-4142-8CC2-BED765F0C289Q37271658-60DE1DC0-EB58-41C1-9819-E0B413F23624Q37275225-D5C6FC8E-7338-4276-B820-3F471FE76EF2Q37461791-E624077B-B4C7-400B-BF39-8C3BEF124A57Q37718523-26CB291C-F49F-4682-A569-C55C58045A92Q37851027-F1F78DA7-4B71-478C-BD77-FEE4F2B5889DQ38131264-B34CBD5E-96A9-48A4-8588-98EFED0717E5Q38249954-54DBA290-BE36-4D57-9E52-83DDD4377310
P2860
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@ast
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@en
type
label
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@ast
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@en
prefLabel
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@ast
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@en
P2093
P1476
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy.
@en
P2093
Katsuhiko Okumura
Kohji Takara
Toshiyuki Sakaeda
P304
P356
10.2174/138161206775201965
P577
2006-01-01T00:00:00Z